Functional outcome of De Quervain’s tenosynovitis with longitudinal incision in surgically treated patients
- 15 Downloads
De Quervain described tenosynovitis of first dorsal compartment more than 120 years ago. Women, particularly of 4th–5th decades, are at more risk of developing disease. Steroid injection has been described as first line of management over many decades, but it is associated with some significant complications like depigmentation of skin, atrophy of subcutaneous tissue, suppurative tenosynovitis and even tendon rupture. Animal studies have also reported increased risk of peritendinous adhesions with steroid injection.
Materials and methods
We prospectively managed 46 cases of De Quervain’s tenosynovitis with longitudinal incision at tertiary care hospital from 2014 to 2016. There were totally 40 patients with 9 males and 31 females between age group of 28 and 62 years. All patients were evaluated using DASH and VAS scores preoperatively and post-operatively.
The mean preoperative DASH score was 42.26 which reduced to 5.37 post-operatively. The mean preoperative VAS score was 7.30 which reduced to 2.33 post-operatively. Intraoperatively, we found peritendinous adhesions in 8 patients and ganglion arising from first dorsal compartment in one patient. Post-operatively, we found hypertrophic scar in 3 patients and persistent numbness to first dorsal web space due to injury to superficial radial nerve in 2 patients. Six patients had recurrent symptoms and required revision surgery.
Surgical release of De Quervain’s tenosynovitis remains the gold standard treatment, and longitudinal incision offers advantage of easy identification of compartment, more complete releases of tendon sheath and peritendinous adhesions and less risk of palmar subluxation of tendons.
KeywordsDe Quervain Surgery Longitudinal incision Functional outcome
Compliance with ethical standards
Conflict of interest
There is no conflict of interest.
Human and animal rights
This article does not contain any studies with animals performed by any of the authors.
A well informed consent was taken from all patients participating in the study.
- 1.de Quervain F (2005) On a form of chronic tendovaginitis (Translated article: Cor-Bl.f.schweiz. Aerzrte 1895:25:389-94). J Hand Surg Br 30(4):388–391Google Scholar
- 3.Johnson CA (1991) Occurrence of de Quervain disease in postpartum women. Fam Pract 32:325–327Google Scholar
- 7.Finkelstein H (1930) Stenosing tendovaginitis at the radial styloid process. J Bone Jt Surg 12A:509–540Google Scholar
- 12.Robinson BS (2003) Rehabilitation of a cellist after surgery for de Quervain’s tenosynovitis and intersection syndrome. Med Probl Perform Artists 18(3):106–112Google Scholar
- 13.Hartzell TL, Rubenstein R, Herman M (2013) Therapeutic modalities—an updated review for the hand surgeon. J Hand Surg 37A:597–621Google Scholar
- 15.Peters-Veluthamaningal C, van der Windt DA, Winters JC, Meyboom-de Jong B (2009) Corticosteroid injection for de Quervain’s tenosynovitis. Cochrane Database Syst Rev 8(3):CD005616Google Scholar
- 23.Froimson A (1993) Tenosynovitis and tennis elbow. In: Green DP (ed) Operative hand surgery, vol 2, 3rd edn. Churchill Livingstone, New York, pp 1989–2006Google Scholar